List of Biotechnology Companies to Watch

PDF version: List of Biotechnology Companies to Watch – by Logan Thrasher Collins 


Nanobodies as therapeutics and as laboratory reagents.


AgeX Therapeutics

Treating aging using stem cell therapies, induced tissue regeneration, related methods.



Developing salt-tolerant rice for ocean agriculture.

Early stage as of May 2021.



Engineering microorganisms and enzymes to degrade environmental pollutants.

Funded by the Ferment Consortium of Ginkgo Bioworks.



Developing computer aided design tools for synthetic biology, making host cell lines for viral vector and biologics manufacturing, constructing genetic parts database.

One of the co-founders is Christopher Voigt.

James Collins is on the scientific advisory board.


Beam Therapeutics

Developing base editor technologies towards therapeutic applications.

David Liu and Feng Zhang are among the co-founders.


BioMarin Pharmaceutical

Enzyme replacement therapies for rare diseases.

During April 2021, announced a collaboration with the Allen Institute to develop AAV gene therapies for rare diseases of the brain.


Bionaut Labs

Microrobotics as a new paradigm for drug delivery.



Developing gene therapies to treat aging, offers tests for determining biological age.

Elizabeth Parrish (the company’s CEO) tested an experimental gene therapy on herself and reports positive results, though some people question whether the therapy actually worked.

George Church and Aubrey de Grey are on the scientific advisory board.

Anders Sandberg is the company’s ethics advisor.


Creative Biolabs

Custom services for antibody engineering, membrane protein production and characterization, bioconjugation, gene therapy development, viral vector engineering, cell therapy development, molecular dynamics simulations, drug development consulting, and more.


Dyno Therapeutics

Using deep learning to improve properties of AAV capsids as a platform technology for gene therapy.

George Church is one of the co-founders.


Editas Medicine

CRISPR-based gene therapy.

George Church, David Liu, Jennifer Doudna, Feng Zhang, and J. Keith Joung are the co-founders.


DNA origami imaging probes, fluorescence microscopy reagents.

First commercial application of DNA origami.


Services in artificial DNA synthesis, synthetic biology, antibodies, cell therapies, enzyme engineering, etc.


Ginkgo Bioworks

Synthetic biology, biomanufacturing, microorganism design, enzyme engineering, etc.

Acquired Gen9 in 2017.


Developing an mRNA-based SARS-CoV-2 vaccine which might protect from all possible variants of the virus.

Pivoted from original plan of developing cancer vaccines using the same technology.

Co-founded by Hannu Rajaniemi, who is also a successful science fiction author.

George Church is an advisor.


Neurotechnology, noninvasive brain-computer interfaces, invasive neural prostheses.

Some noninvasive products anticipated to be released during 2021.

Founded by Bryan Johnson who personally invested $54 million.

Raised an additional $53 million from outside investors.

Early goal is to help treat brain disease, has ambitions to enable human enhancement.



Peptide nanoparticles for targeted CRISPR-Cas gene therapy delivery, immunotherapy, hematological gene therapy, aging treatments.

Founded by Andre Watson.

Mammoth Biosciences

CRISPR-based diagnostics.

Jennifer Doudna is one of the co-founders.


System for barcoding protein therapeutics to enable high-throughput design and testing in complex environments, machine learning to optimize drug design.

George Church is one of the co-founders.


Biomedical technologies which utilize mRNA inside of lipid nanoparticles; application areas include drug discovery, drug development, and vaccines.

Major player in COVID-19 pandemic since it was one of the first companies which developed and distributed SARS-CoV-2 vaccines to the world.



High-bandwidth brain-machine interfaces, surgical robots which implant the interfaces in a manner resembling a sewing machine.

Early goal is to help treat brain disease, has ambitions to enable human enhancement.

Founded by Elon Musk and others, highly publicized by Elon Musk.

Has done testing on rats, pigs, monkeys, and other animals as of April 2021.



Portable medical imaging technologies which employ novel optoelectronics, lasers, and holographic systems.

Wearable imaging technologies which could be 1,000x cheaper than MRI and achieve similar or better results.

Has speculated that their technology might eventually allow telepathic communication.



3D tissue bioprinting for in vivo clinical applications, in vitro tissue models for disease modeling and toxicology.

Long-term goal is to print entire human organs for transplants.


Oxford Nanopore Technologies

Portable nanopore sequencing devices, high-throughput desktop nanopore sequencing devices, sample preparation kits.

The company states that they have the first and only nanopore DNA and RNA sequencing platform as of May 2021.



Genetically modified male insects which curb the reproduction of populations of their species in the wild, acting as a precise and environmentally friendly way of controlling dangerous pests that spread disease or destroy crops.

After years of battles with activists and regulatory bodies, the company will release 750 million genetically modified mosquitos in the Florida Keys (the first time this has been done in the U.S.) with the goal of reducing rates of illnesses such as yellow fever and dengue.  


Panacea Longevity

Enhancing longevity and health using a fasting-mimetic metabolite supplementation.

Early stage as of May 2021.


Mass-produced insect larvae as an affordable way of manufacturing recombinant proteins.

Early stage as of May 2021.

Repair Biotechnologies

Developing a cholesterol degrading platform therapy which can reverse atherosclerosis.

The CEO, who is known as Reason, is outspoken about the need to combat aging.

Has preclinical proof-of-concept as of May 2021.


New manufacturing platforms to service partners for development and scaling of gene therapies, cell therapies, vaccines, protein therapies, and more.

Received $800 million in funding during 2020.

Sherlock Biosciences

CRISPR-based diagnostics.

Feng Zhang is one of the co-founders.


Proteomics platform called SomaScan for protein biomarker discovery which aids researchers in the development of new diagnostics.

SomaScan is an aptamer-based platform which can simultaneously measure 7,000 protein biomarkers.

Founded by Larry Gold, who is the inventor of SELEX.

Twist Bioscience

Artificial DNA synthesis, synthetic biology.

Vault Pharma

Protein vault nanocompartments as a drug delivery platform to treat cancers and other diseases, protein vaults as a vaccine platform.

Co-founded by Leonard Rome.


Services in vector cloning, virus packaging, library construction, cell lines, etc.



Synthetic biology, metabolic engineering, biomanufacturing of materials and compounds as a substitute for chemical engineering practices.

64x Bio

High-throughput screening and computational design of new mammalian cell lines for manufacturing gene and cell therapies.

George Church and Pamela Silver are among the co-founders.

10x Genomics

Spatial transcriptomics, genomics, proteomics, immune cell profiling, etc.

Acquired ReadCoor and Cartana in 2020.

banner is a fluorescence microscopy image of adenovirus-infected mammalian cells and represents data generated by Logan Thrasher Collins

One Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s